Reports for BUPRENORPHINE
Ingredient
BUPRENORPHINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
BUTRANS 5 | 5MCG | PATCH | Resolved | 2021-05-13 | 2021-05-27 | 139259 |
SUBLOCADE | 300MG | SOLUTION (EXTENDED RELEASE) | Resolved | 2020-09-01 | 2021-01-27 | 123466 |
SUBLOCADE | 100MG | SOLUTION (EXTENDED RELEASE) | Resolved | 2020-09-01 | 2021-03-10 | 123461 |
BUTRANS 20 | 20MCG | PATCH | Resolved | 2020-06-02 | 2020-06-17 | 116371 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 | ||
BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
Showing 1 to 6 of 6